Results 101 to 110 of about 230,512 (314)

Fpga Implementations Of Sorters For Non-Linear Filters

open access: yes, 2004
Publication in the conference proceedings of EUSIPCO, Viena, Austria ...
Boaz Hirschl, Leonid P. Yaroslavsky
openaire   +2 more sources

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

open access: yesMolecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh   +12 more
wiley   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Adaptive Non-linear Filtering Technique for Image Restoration

open access: yesCoRR, 2010
Accepted.
S. K. Satpathy   +4 more
openaire   +3 more sources

Non-fragile sampled data $H_\infty $ filtering of general continuous Markov jump linear systems

open access: yes, 2014
summary:This paper is concerned with the non-fragile sampled data $H_\infty$ filtering problem for continuous Markov jump linear system with partly known transition probabilities (TPs).
Yuan, Yuhao   +3 more
core   +1 more source

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

open access: yesMolecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain   +10 more
wiley   +1 more source

Amplitude Suppression of Nongaussian Sea Clutter in a Coherent Bandpass Path of the Receiver

open access: yesИзвестия высших учебных заведений России: Радиоэлектроника, 2016
The method of non-linear amplitude suppression of radar clutter from a sea surface in the coherent band path of the receiver is considered. The model of the most adequate nongaussian radar clutter from the rough sea surface which envelope is based on K ...
E. A. Milashchenko, A. A. Yazovsky
doaj  

Discretised Non-Linear Filtering for Dynamic Latent Variable Models: with Application to Stochastic Volatility [PDF]

open access: yes
Filtering techniques are often applied to the estimation of dynamic latent variable models. However, these techniques are often based on a set assumptions which restrict models to be specified in a linear state-space form.
Scott I. White   +2 more
core  

Robust H∞ control of time-varying systems with stochastic non-linearities: the finite-horizon case

open access: yes, 2010
The official published version can be obtained from the link below.This paper is concerned with the robust H∞ control problem for the class of uncertain non-linear discrete time-varying stochastic systems with a covariance constraint.
Wang, Z, Ma, L, Bo, Y, Guo, Z
core   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy